LAVORINI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.606
EU - Europa 8.897
AS - Asia 6.067
SA - Sud America 916
AF - Africa 173
OC - Oceania 107
Continente sconosciuto - Info sul continente non disponibili 3
Totale 27.769
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.458
PL - Polonia 2.947
RU - Federazione Russa 2.495
SG - Singapore 1.580
CN - Cina 1.505
HK - Hong Kong 910
IT - Italia 849
VN - Vietnam 797
BR - Brasile 728
IE - Irlanda 607
GB - Regno Unito 523
KR - Corea 509
SE - Svezia 328
FI - Finlandia 295
FR - Francia 236
DE - Germania 218
IN - India 189
NL - Olanda 125
ID - Indonesia 119
UA - Ucraina 113
AU - Australia 104
AR - Argentina 87
JO - Giordania 80
CA - Canada 75
BD - Bangladesh 69
JP - Giappone 66
CH - Svizzera 47
CI - Costa d'Avorio 41
MX - Messico 41
TR - Turchia 40
IQ - Iraq 38
EC - Ecuador 34
ES - Italia 32
ZA - Sudafrica 27
PK - Pakistan 25
SA - Arabia Saudita 23
VE - Venezuela 20
NG - Nigeria 19
MA - Marocco 18
BE - Belgio 14
BJ - Benin 13
CZ - Repubblica Ceca 13
CO - Colombia 12
PY - Paraguay 12
UZ - Uzbekistan 12
PH - Filippine 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AZ - Azerbaigian 9
CL - Cile 9
KE - Kenya 9
OM - Oman 9
TN - Tunisia 9
KZ - Kazakistan 8
DZ - Algeria 7
EG - Egitto 7
RO - Romania 7
SC - Seychelles 7
TH - Thailandia 7
IR - Iran 6
JM - Giamaica 6
LT - Lituania 6
NP - Nepal 6
AT - Austria 5
CR - Costa Rica 5
IL - Israele 5
MY - Malesia 5
BG - Bulgaria 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
RS - Serbia 4
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
LI - Liechtenstein 3
MN - Mongolia 3
MU - Mauritius 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
MM - Myanmar 2
PR - Porto Rico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TZ - Tanzania 2
UY - Uruguay 2
AM - Armenia 1
BY - Bielorussia 1
Totale 27.746
Salva come PNG Salva come JPEG
Città #
Warsaw 2.941
Santa Clara 2.537
Ashburn 1.418
Singapore 1.104
Fairfield 1.035
Hong Kong 764
Dublin 599
Seoul 506
Woodbridge 444
Chandler 413
Seattle 412
Cambridge 391
Houston 375
San Jose 373
Hefei 349
Wilmington 338
Frodsham 325
Beijing 281
Ho Chi Minh City 219
The Dalles 197
Hanoi 187
Altamura 178
Ann Arbor 177
Council Bluffs 174
Lawrence 170
Lauterbourg 166
Helsinki 163
Princeton 162
Los Angeles 159
Florence 150
Moscow 150
Jacksonville 143
Buffalo 134
Boston 123
Melbourne 95
Dallas 91
Dong Ket 90
Jakarta 88
Mumbai 88
Milan 86
Amsterdam 81
San Diego 78
Shanghai 78
New York 74
Munich 68
São Paulo 64
Kent 62
Medford 62
Tokyo 62
Boardman 59
Bern 44
Abidjan 41
London 41
Frankfurt am Main 39
Falls Church 37
Redondo Beach 37
Norwalk 36
Clifton 34
Haiphong 34
Guangzhou 31
Turku 31
Manchester 30
Phoenix 30
Rome 30
Da Nang 29
Lappeenranta 27
Toronto 25
Barcelona 24
Chicago 24
Orem 24
Bengaluru 23
Washington 22
Paris 21
Yubileyny 21
Rio de Janeiro 20
Hillsboro 18
Abuja 17
Baghdad 17
Montreal 17
Brooklyn 16
Curitiba 16
Denver 16
Johannesburg 16
Belo Horizonte 15
Biên Hòa 15
Chennai 15
Shenzhen 15
Izmir 14
San Francisco 14
Cotonou 13
Brasília 12
Brussels 12
Nanjing 12
Siena 12
Tashkent 12
Thái Bình 12
West Jordan 12
Hải Dương 11
Mexico City 11
Porto Alegre 11
Totale 19.589
Salva come PNG Salva come JPEG
Nome #
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 530
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 375
Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study 354
A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough. 317
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 313
Effect of an anti-reflux medical device in the control of deflation cough: A placebo-controlled comparative study with an antacid drug in chronic coughers 303
100 Years of Drug Delivery to the Lungs 297
Pulmonary hypertension nosography: are all patients classifiable? 292
Gorham-Stout Disease Management during Pregnancy 275
Cough and ventilatory adjustments evoked by aerosolised capsaicin and distilled water (fog) in man 272
A 57-year-old chronic cougher with somatically evoked cough. 269
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 265
Inhaler technique: Facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) 263
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 253
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy 250
Recent advances in capsule-based dry powder inhaler technology 239
Critical inhaler errors in asthma and COPD: A systematic review of impact on health outcomes 238
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 235
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here? 225
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 221
Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease 217
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 216
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 215
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting 213
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 211
The lung microbiome: clinical and therapeutic implications 208
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: The Easy Low Instruction Over Time (ELIOT) study 206
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 199
A multinational observational study identifying primary care patients at risk of overestimation of asthma control 196
A noninvasive electromyographic study on threshold and intensity of cough in humans. 194
Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2 194
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 190
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 189
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices 189
The ThinICE protocol: the combination of cryobiopsy and ultraThin bronchoscopy for the peripheral lung nodule 188
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes 188
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 183
Fog-induced Cough With Impaired Respiratory Sensation in Congenital Central Hypoventilation Syndrome. 181
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 180
The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough 178
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 174
Voluntary and reflex cough: Similarities and differences 173
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 173
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 172
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 171
Somatic points for cough and urge to cough in chronic coughers 171
Breathing pattern during fog challenges in humans 171
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 170
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: Impact on patient outcome 170
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 169
Validation of a method to assess emphysema severity by spirometry in the COPDGene study. 169
Respiratory rate assessments using a dual-accelerometer device 168
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. 168
Retail sales of inhalation devices in European countries: So much for a global policy 165
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 165
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 163
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 161
Coughing in laryngectomized patients. 161
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape 161
The challenge of delivering therapeutic aerosols to asthma patients 161
A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers 161
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 161
Effects of saline nebulization on SARS-CoV-2 RNA spreading and exhaled bio-aerosol particles in COVID-19 patients 160
The Clinical Value of Deflation Cough in Chronic Coughers with Reflux Symptoms 160
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 160
Presentation and progression of MPO-ANCA interstitial lung disease 159
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 159
M4 muscarinic receptors mediate acetylcholine-induced suppressant effects on the cough reflex in the caudal nucleus tractus solitarii of the rabbit 156
Inhaler technique and patient's preference for dry powder inhaler devices 156
First Exploration of the Altered Microbial Gut-Lung Axis in the Pathogenesis of Human Refractory Chronic Cough 154
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients 154
The ADMIT series – Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma 153
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 152
EP1.04-02 Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study 152
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 150
Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices 150
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 149
Repeatability of cough-related variables during fog challenges at threshold and suprathreshold stimulus intensity in humans. 149
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis 149
Respiratory expulsive efforts evoked by maximal lung emptying. 148
Airway response to fenoterol hydrobromide and oxitropium bromide alone or in sequence in stable COPD patients 148
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium 147
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes 147
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: A randomised, crossover, open-label study 147
Switching treatments in COPD: Implications for costs and treatment adherence 146
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series 146
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center 146
The Fontana paradoxical reflex? 144
Classification of COPD patients by using a standardised diagnostic questionnaire 143
ADMIT Working Group. Inhaler choice and inhalation technique: key factors for asthma control. 143
Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases 142
Diagnostic strategies for suspected pulmonary embolism 142
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy 142
Defective motor control of coughing in Parkinson's disease. 140
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients 140
The fi rst tissue-engineered airway transplantation: 5-year follow-up results 140
Correct inhalation technique is critical in achieving good asthma control 139
“Adrenaline junkie”: a case report of repeated use of epinephrine 137
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases 137
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 135
Totale 19.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 0 76 160
2021/20221.091 51 94 84 32 39 97 37 83 64 62 125 323
2022/20232.380 273 458 76 158 142 407 354 119 220 44 61 68
2023/20241.081 38 131 197 90 90 128 42 149 16 98 62 40
2024/20257.476 251 733 451 1.034 2.236 990 185 449 328 199 283 337
2025/20268.943 971 1.543 1.017 911 896 337 1.177 491 645 651 304 0
Totale 28.003